DOI QR코드

DOI QR Code

Imaging for Screening/Surveillance of Pancreatic Cancer: A Glimpse of Hope

  • Khaled Y. Elbanna (Joint Department of Medical Imaging, University of Toronto) ;
  • Hyun-Jung Jang (Joint Department of Medical Imaging, University of Toronto) ;
  • Tae Kyoung Kim (Joint Department of Medical Imaging, University of Toronto)
  • Received : 2023.01.02
  • Accepted : 2023.02.08
  • Published : 2023.04.01

Abstract

Keywords

References

  1. Pereira SP, Oldfield L, Ney A, Hart PA, Keane MG, Pandol SJ, et al. Early detection of pancreatic cancer. Lancet Gastroenterol Hepatol 2020;5:698-710 https://doi.org/10.1016/S2468-1253(19)30416-9
  2. Klatte DCF, Boekestijn B, Wasser MNJM, Feshtali Shahbazi S, Ibrahim IS, Mieog JSD, et al. Pancreatic cancer surveillance in carriers of a germline CDKN2A pathogenic variant: yield and outcomes of a 20-year prospective follow-up. J Clin Oncol 2022;40:3267-3277 https://doi.org/10.1200/JCO.22.00194
  3. Dbouk M, Katona BW, Brand RE, Chak A, Syngal S, Farrell JJ, et al. The multicenter cancer of pancreas screening study: impact on stage and survival. J Clin Oncol 2022;40:3257-3266 https://doi.org/10.1200/JCO.22.00298
  4. Miller FH, Lopes Vendrami C, Recht HS, Wood CG, Mittal P, Keswani RN, et al. Pancreatic cystic lesions and malignancy: assessment, guidelines, and the field defect. Radiographics 2022;42:87-105 https://doi.org/10.1148/rg.210056
  5. Surci N, Marchegiani G, Andrianello S, Pollini T, Muhlbacher J, Jomrich G, et al. The faith of non-surveilled pancreatic cysts: a bicentric retrospective study. Eur J Surg Oncol 2022;48:89-94 https://doi.org/10.1016/j.ejso.2021.06.007
  6. Balduzzi A, Marchegiani G, Pollini T, Biancotto M, Caravati A, Stigliani E, et al. Systematic review and meta-analysis of observational studies on BD-IPMNS progression to malignancy. Pancreatology 2021;21:1135-1145 https://doi.org/10.1016/j.pan.2021.04.009
  7. Overbeek KA, Levink IJM, Koopmann BDM, Harinck F, Konings ICAW, Ausems MGEM, et al. Long-term yield of pancreatic cancer surveillance in high-risk individuals. Gut 2022;71:1152-1160 https://doi.org/10.1136/gutjnl-2020-323611
  8. Ardeshna DR, Rangwani S, Cao T, Pawlik TM, Stanich PP, Krishna SG. Intraductal papillary mucinous neoplasms in hereditary cancer syndromes. Biomedicines 2022;10:1475
  9. Kulkarni NM, Mannelli L, Zins M, Bhosale PR, Arif-Tiwari H, Brook OR, et al. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals. Abdom Radiol (NY) 2020;45:729-742 https://doi.org/10.1007/s00261-019-02290-y
  10. Burk KS, Lo GC, Gee MS, Sahani DV. Imaging and screening of pancreatic cancer. Radiol Clin North Am 2017;55:1223-1234 https://doi.org/10.1016/j.rcl.2017.06.006
  11. Huang C, Simeone DM, Luk L, Hecht EM, Khatri G, Kambadakone A, et al. Standardization of MRI screening and reporting in individuals with elevated risk of pancreatic ductal adenocarcinoma: consensus statement of the PRECEDE consortium. AJR Am J Roentgenol 2022;219:903-914 https://doi.org/10.2214/AJR.22.27859
  12. Elbanna KY, Jang HJ, Kim TK. Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: a comprehensive review. Insights Imaging 2020;11:58